XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 114,322 $ 49,060
Investments in marketable securities 448,198 309,502
Accounts receivable 10,836 9,464
Inventories 8,070 4,623
Prepaid expenses and other current assets 10,607 19,316
Total current assets 592,033 391,965
Investments in marketable securities 42,673  
Property and equipment, less accumulated depreciation of $13,461 and $12,515 at March 31, 2018 and December 31, 2017, respectively 8,910 9,062
In-process research & development 23,000 23,000
Goodwill 197,797 197,797
Other non-current assets 5,592 5,200
Total Assets 870,005 627,024
Current liabilities:    
Accounts payable, accrued expenses, and other current liabilities 43,678 53,890
Deferred reimbursements 7,750 7,750
Derivative liability 80,577  
Contingent consideration payable 8,700 8,400
Total current liabilities 140,705 70,040
Deferred reimbursements 14,156 14,156
Convertible notes 166,768 164,167
Contingent consideration payable 17,800 17,000
Deferred income taxes 6,465 6,465
Other non-current liability 2,494 2,346
Total liabilities 348,388 274,174
Commitments and contingencies
Stockholders' equity:    
Common stock, $0.01 par value, 250,000,000 shares authorized 187,972,218 and 166,989,790 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively 1,929 1,721
Additional paid-in capital 1,621,479 1,400,758
Accumulated other comprehensive loss:    
Foreign currency translation adjustment (3,847) (1,659)
Unrealized loss on available-for-sale securities (877) (436)
Warrants 16,076 16,076
Accumulated deficit (1,113,143) (1,063,610)
Total stockholders' equity 521,617 352,850
Total Liabilities and Stockholders' Equity $ 870,005 $ 627,024